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Several recent prospective studies relating
blood lead to behavior in children (1-9)
have implicated lead as having a negative
influence on young children's cognitive
development. Although in some of these
studies early relationships with prenatal
exposure disappear with time, several stud-
ies suggest that postnatal exposure is related
to later outcomes (1-5,8,9). Bellinger et al.
(2,3) reported that blood lead level at 2
years ofage is negatively related to cognitive
outcome at 4.5 and 10 years. Australian
investigators (1,5) reported that integrated
blood lead levels are negatively related to
performance at 4 and 7 years of age, and
blood lead levels at 2 and 3 years con-
tributed most to the integrated blood lead
concentration. Wasserman and colleagues
(9) found that blood lead levels after 18
months ofage were more strongly related to
cognitive development at 4 years of age
than blood lead levels before 18 months. In
all of these studies, the strongest relation-
ships at 4 years were between blood lead
and perceptual-motor performance on the
McCarthy scales. Although the results of
the Cincinnati study (10) have often been
nonsignificant when appropriate covariates
were controlled for, Dietrich et al. (4)
found that decrements in performance on
several subscales on a test offine motor pro-
ficiency at 6 years were associated with both
current and earlier blood lead levels. These
results suggest that blood lead levels
around 2 or 3 years of age contribute to
cognitive development, particularly percep-
tual-motor skills. The general timing of
this contribution coincides with the natur-
al course of blood lead in children for
whom there is no systematic intervention;
blood lead levels peak between 18 and 30
months and decline slowly but steadily
thereafter (1,4).
The age of 2 years may be especially
important in neurobiological development
as synaptic connections within the brain
reach a peak and are then selectively
reduced (11,12). Goldstein (11) suggests
that lead may augment the background
level of neurotransmitter activity and
thereby diminish the efficiency with which
these connections are pruned. In this way,
the cognitive development of children
around 2 years of age may be particularly
vulnerable to the effects of lead. Another
factor is that children around this age are
more likely than older children to be iron
deficient. In our sample (13), for example,
52% ofchildren under 3 years had ferritin
concentrations of less than 16 ng/ml.
Wasserman et al. (8) found that both lead
and iron contributed to cognitive perfor-
mance in a group of 2-year-old children.
Because iron levels may influence chil-
dren's neurological and cognitive develop-
ment (14) and also affect absorption and
excretion oflead (15,16), they may interact
with lead in influencing development and
the outcomes ofintervention.
We recently reported (13) an inverse
relationship between declining blood lead
levels and improvements in cognitive perfor-
mance in 1- to 7-year-old children who par-
ticipated in a comprehensive intervention
program to reduce blood lead levels. The
average trend in this group was significant,
but there was a great deal ofvariation. The
variability stemmed in part from the neces-
sary use of different tests at different ages
and from variations in iron levels and treat-
ment patterns. We thus decided to examine
in more detail the data of a subgroup of
these children who were close to 2 years old
at enrollment and who were administered
only the Bayley Scale of Mental
Development during the study. The use ofa
single test and the narrowness of the age
range meant that many test items were com-
mon across the group and permitted an
examination ofparticular types ofitems.
In summary, the two questions motivat-
ing the analyses were related specifically to
the age ofthe children. First, if2 year olds
are particularly vulnerable to the effects of
lead, will they also be particularly respon-
sive to intervention to reduce blood lead
levels? Second, given the prevalence ofiron
deficiency at this age, are iron-deficient
children less responsive than iron-sufficient
children to such intervention?
Methods
The goal of the analyses reported here was
to explore the relationships between cogni-
tive performance and both iron status and
changing lead levels in a sample ofchildren
between 18 and 30 months ofage. The chil-
Address correspondence to H. A. Ruff, Room 222,
Kennedy Center, Albert Einstein College of
Medicine, 1300 Morris Park Avenue, Bronx, NY
10461 USA.
This research was supported by grants ES04039
from the National Institute of Environmental
Health Sciences; 86109286 from the W. T. Grant
Foundation; and a Research Scientist Development
Award, MH00652, from the National Institute of
Mental Health. The research was also facilitated by
grant HD07199 from the National Institute of
Child Health and Human Development to the Rose
F. Kennedy Center for Research in Mental
Retardation and Human Development at Albert
Einstein College ofMedicine.
Received 17July 1995; accepted 27 October 1995.
Volume 104, Number2, February 1996 * Environmental Health Perspectives 180Articles * Lead and iron in cognitive development
dren were evaluated at three time points in
the course of a 6-month intervention peri-
od. The intervention included abatement
procedures in the home to reduce exposure
to lead, chelation treatment if indicated by
the results of the lead mobilization test
(LMT), and iron supplementation for those
children who were iron deficient as deter-
mined byserum ferritin levels (13).
The study was approved by the local
Institutional Review Boards, and consent
was obtained from the parents or guardians
of all participating children. Children par-
ticipated in the study if they had not been
treated previously for lead poisoning, their
blood lead (BPb) levels at the time ofenroll-
ment were between 25 and 54 pg/dl, and
their levels of erythrocyte protoporphyrin
(EP) were >34 jig/dI. The children's clinical
management throughout the study followed
standard procedures. Ifthe child's LMT was
positive, the child was hospitalized for treat-
ment with CaNa2EDTA. If the child was
iron deficient (ferritin <16 ng/ml), oral iron
was prescribed (6 mg/kg/day). Depending
on the diagnostic outcomes, the enrolled
children could be given both forms oftreat-
ment, neither form, or either one of them
alone. For all children, there were sequential
inspections of the home and attempts to
eliminate exposure to lead paint through
existing housing codes. That these efforts
were at least partially successful is demon-
strated by a significant decline in exposure
as measured during home visits (unpub-
lished observations).
The children's cognitive development
and behavior were evaluated at three time
points, but we report here the data from
the first and last visits: 1) time 1: approxi-
mately 1 week after enrollment and before
the treatment course was determined, and
2) time 3: approximately 6 months after
the first visit. The dependent variable was
the child's performance on the Bayley Scale
of Mental Development (17). Assessors
were blind to the treatment status of chil-
dren and to their BPbs.
Sample and Procedures
We selected 42 children (26 males, 16
females) from the 154 children who consti-
tuted the sample in our recent report (13).
The selection criteria were as follows: 1)
age at enrollment ofat least 18 months but
no more than 30 months; 2) complete data
for BPb, EP, and cognitive functioning at
both time points and for all background
factors except mother's IQ; and 3) use of
the Bayley Scale at both visits. The subsam-
ple was 69% Hispanic and 31% black.
Early in the week after enrollment, each
child was evaluated with the Bayley Scales
of Mental Development. Within 3 days of
this evaluation, each child underwent an
LMT; the LMT consists ofthe intramuscu-
lar administration of a single dose of
CaNa2EDTA followed by an 8-hr urine
collection for determination oflead. A new
blood sample was obtained on the same day
and analyzed for BPb, EP, and ferritin.
Based on the results ofthe LMT, the child
was either hospitalized for a 5-day course of
CaNa2EDTA treatment (1 g/m2/day) or
not. Oral iron (6 mg/kg/day) was pre-
scribed if necessary, and a housing inspec-
tion was conducted. Except for the LMT,
which depended on current BPb, this entire
process was repeated approximately 6
months later whether or not the child had
been hospitalized for EDTA chelation treat-
ment. The cognitive and biochemical mea-
sures are therefore closelylinked in time.
Measures
The dependent measure of cognitive func-
tioning was the mental development index
(MDI) from the Bayley Scales of Infant
Development (17). The MDI is a stan-
dardized score with a mean of 100 and a
standard deviation of 16. In addition to the
global score, we analyzed the cognitive and
language subscales according to the Kent
scoring system. These scores are age equiva-
lents in months. Despite the label, the cog-
nitive subscale consists almost exclusively
of perceptual-motor items such as perfor-
mance on pegboards and formboards, imi-
tating crayon strokes, and stacking blocks.
The language subscale includes both com-
prehension and production ofsingle words,
simple combinations, and comprehension
ofsimple commands.
There were several biochemical mea-
sures used in the analyses as independent or
moderator variables: BPb, EP, ferritin, and
several hematologic indices. BPb (95%
confidence limit for the reliability ofdupli-
cate samples, ± 1.0 pg/dl) was measured by
graphite furnace atomic absorption spec-
troscopy. The EP level was determined by
the extraction method of Piomelli et al.
(18). Our laboratory participates success-
fully in the proficiency testing programs of
New York City, New York State, and The
Centers for Disease Control.
Ferritin was measured by radioim-
munoassay. The intra-assay and interassay
coefficients of variation were 3% and 4%,
respectively. Ferritin levels were missing at
the last time point for five children, for
whom data were otherwise complete. These
missing data points were replaced by
regressing ferritin on age in the entire sam-
ple (13) and using the resulting values to
estimate missing ferritin values; this process
resulted in replacement values of ferritin
>20, as mean replacement would have.
Complete blood counts were also conduct-
ed by the hospital laboratory, which provid-
ed information about hematologic variables.
To form groups for use as a categorical vari-
able, the children were separated into those
with low iron and those with adequate iron.
There were 20 (48%) children whose fer-
ritin was <16 ng/ml at time 1; 14 of them
had average ferritin levels over the course of
the study of<16 ng/ml. This cut-off, which
determined whether oral iron was pre-
scribed, was based on a large population-
based study ofhealthy, nonanemic children
(19) and has been used successfully by us
and others to indicate the need for interven-
tion (13,20). Ofthe 22 children whose fer-
ritin was >16 ng/ml at time 1, 1 child with
a ferritin level of16 had ahemoglobin (Hb)
level of 10.5 g/dl, indicative of mild ane-
mia, and was moved to the iron-deficient
group. Ten children in the iron-deficient
group fit the criteria for mild to moderate
anemia [Hb <11 g/dl (21)]; 11 were judged
to be deficient or depleted (ferritin <16
ng/ml, Hb >11 g/dl).
The distributions of all variables were
checked for this sample, and any outlying
values, as determined by the statistical pro-
gram, were pulled in to 1 point above (or
below) the next largest (or smallest) value, a
process known as winsorizing (22). One or
two values changed on three time 1 vari-
ables (BPb, mean corpuscular volume, and
urinary Pb), four change variables (MDI,
perceptual-motor score, ferritin, Hb), and
one background variable (socioeconomic
status; SES); these represent 27% ofdistri-
butions tested. These changes increased the
precision, but not the direction or general
magnitude, ofthe results.
A number ofbackground variables were
considered; these included SES, score on the
Caldwell HOME scale as a percentage of
items scored positively (23), maternal IQ
(replaced with the mean in five cases of
missing data), child's birth order, number of
people in the household, number ofprena-
tal and perinatal complications, sex, lan-
guage of test administration (Spanish/
English), race, and age. We controlled those
variables that were associated with both
dependent and independent variables with a
probability of<0.15 (24). We also included
background variables related to the depen-
dent variable iftheir inclusion increased the
precision ofthe particular model being test-
ed (25). SES, Caldwell HOME score, and
language oftest administration were used in
analyses ofchange in MDI; covariates added
to other models will be noted as relevant.
Analyses
For the main analyses, we examined
regressed change in MDI or subtest scores
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in relation to regressed change in BPb or
other biochemical or hematologic variables
during the study period (26). For example,
in assessing the relationship between
change in MDI and change in BPb, we
controlled for initial levels of BPb and
MDI. Potential interactions between
change in BPb and the covariates and back-
ground variables were tested; none was sig-
nificant. Because ofour interest in iron sta-
tus as apotential modifier or confounder of
the relationship between change in BPb
and change in MDI, iron status at time 1
was entered into the regression equation as
a categorical variable. Finally, the term rep-
resenting the interaction between iron sta-
tus and change in BPb was entered to
determine whether the interaction account-
ed for a significant increase in R2. This
same procedure was followed for most of
the analyses involving the entire group of
children. All significant relationships were
tested for the effects of individuals with
undue influence. Analyses were conducted
with the SYSTAT computer program.
Results
Table 1 presents descriptive data for iron-
deficient and iron-sufficient subgroups at
time 1. The groups differed mainly on the
iron-related measures, as expected. The
iron-deficient children were, by definition,
lower in ferritin [t (40) = 8.2, p < 0.001];
they were also significantly lower in mean
ferritin over 6 months [t (40 df) = 6.1, p
<0.001], Hb [t (40 df) = 2.8, p = 0.008],
MCV [t (40 df) = 3.1, p = 0.003], and
mean corpuscular hemoglobin [MCH; t
(40 df) = 3.0, p = 0.005]. There was a
marginally larger proportion ofgirls in the
iron-deficient group [t (40 df) = 1.9, p =
0.06]. Although iron-deficient children
were less likely to receive chelation treat-
ment, only 33% (7/21) of the iron-suffi-
cient children underwent chelation therapy
during the course of the 6-month study.
The two groups did not differ on any other
variables, including their initial cognitive
scores and their initial BPb levels.
Relationships between Cognitive and
Biochemical Measures
The analyses did not reveal any relation-
ships at time 1 between the Bayley MDI or
separate subscale scores and BPb, EP, or
ferritin levels in the whole group or within
either the iron-deficient or iron-sufficient
groups. In the iron-deficient group, MDI
was positively related to Hb level (r= 0.51,
p = 0.02) and hematocrit (Hct; r = 0.56, p
= 0.02). Neither ofthese was significant for
the iron-sufficient children. With age con-
trolled, the perceptual-motor and language
subscales for the iron-deficient children
were related to Hb (rs = 0.48 and 0.55) and
Hct (rs = 0.51 and 0.54) at time 1, and the
language subscale was also related to MCV
(r= 0.51).
Relationship between Cognitive
Change and BPb Change
In the analysis of the relationship between
changes in MDI over 6 months and the
concurrent changes in BPb, the regression
coefficient (p) for BPb change was -0.344,
not too different from the -0.310 reported
for the age range 1-7 years (13). The result
was not significant, and iron status alone
Table 1. Comparison of iron-deficient and iron-suf-
ficient children attime 1
Mean (SD)
Iron deficient Iron sufficient
Variable (n= 21) (n= 21)
Iron-related
Ferritin 10.0 (3.2) 26.5 (8.7)
Mean ferritina 14.3 (5.3) 23.4(4.4)
Hemoglobin 11.2 (1.0) 12.0 (0.8)
Hematocrit 35.2 (2.9) 36.8 (2.8)
MCV 71.0 (6.6) 76.4 (4.5)
MCH 22.6 (3.0) 24.9 (2.0)
Background
Age 23.8 (3.5) 23.6 (3.6)
SES 19.2 (6.9) 16.6 (6.2)
Mother's IQ 94.9 (9.3) 91.3 (10.1)
HOMEb 0.66 (.13) 0.62 (.11)
Birth order 2.4 (1.5) 2.8 (1.8)
No. in household 4.8 (1.7) 4.8 (1.3)
No. of complicationsc 2.0 (1.6) 2.2 (1.9)
% Female 52 24
% Hispanic 67 71
% Tests in Spanish 52 52
Lead and cognitive
MDI 78.8 (10.9) 77.1 (12.3)
P-M scored 20.5 (3.4) 19.8 (2.1)
Language scored 19.3 (3.0) 18.2 (3.5)
BPb 28.3 (6.0) 30.4 (6.1)
EP 76.2 (36.5) 85.2 (35.8)
% Receiving chelation 11 33
Abbreviations: MCV, mean corpuscular volume;
MCH, mean corpuscular hemoglobin; SES, socioe-
conomic status; EP, erythrocyte protoporphyrin;
MDI, mental development index from Bayley
Scale; P-M, perceptual-motor subscale; BPb,
blood lead level.
aMean ferritin level over 6 months.
bHOME = Caldwell score.
cNumber of prenatal and perinatal complications.
dAge equivalent in months.
Table 2. Hierarchical regression models and increases in R2forvariables used to predict change in mental development index(MDI)a
R Increase in R2 p-value
MDI change = Constant + MDI atTime 1 (MDI1) 0.31 0.095 0.05
MDI change = Constant + MDI1 + Background Variablesb 0.57 0.22 0.02
MDI change = Constant + MDI1 + Background + Blood Lead atTime 1 (BPb1) + BPb change 0.61 0.05 NS
MDI change = Constant + MDI1 + Background + BPb1 + BPb Change + IronStatus (Fe) 0.62 0.01 NS
MDI change = Constant + MDI1 + Background + BPb1 + BPb Change + Fe + FeeBPbl 0.63 0.01 NS
MDI change = Constant + MDI1 + Background + BPb1 + BPb Change + Fe +Fe.BPbl + Fe.BPb Change 0.72 0.12 0.007
aEach step in this table represents the addition ofthe underlined variable or set ofvariables to showthe consequent increase in the amount ofvariance account-
ed for in change in MDI over 6 months.
bThe set of background variables was socioeconomic status, score on HOME, and language oftest administration.
Table 3. Unadjusted and adjusted means for BPb and MDI attimes 1 and 3for subgroups based on degree of change in BPb
Change in BPb Change in MDI Change in P-M score
BPb, (pg/dl) (standardized points) (Age equivalent, months)
BPb change groups (pg/dl) Unadjusted Adjusteda MDI1 Unadjusted Adjustedb P-M1 Unadjusted Adjustedc
Large declines (n = 6) 34.2 -14.5 -13.4 80.0 + 5.3 + 7.9 19.8 + 5.6 + 6.1
Medium declines (n= 8) 30.1 -9.6 -9.7 73.1 +0.8 +1.4 19.6 + 4.6 +4.5
Small declines/increases (n =7) 27.4 -2.1 -3.0 79.1 - 4.3 - 7.2 20.1 + 3.5 + 3.1
Abbreviations: BPb, blood lead; MDI, mental development index of Bayley Scale; P-M, perceptual-motor subscale.
aAdjusted for BPb attime 1.
bAdjusted for BPb and MDI attime 1.
cAdjusted for BPb and P-M score attime 1.
Volume 104, Number2, February 1996 * Environmental Health Perspectives 182Articles - Lead and iron in cognitive development
did not increase the R2, nor did the inter-
action between iron status and initial BPb
level. However, when the interaction
between iron status and change in BPb was
entered into the equation, the R2 increased
by 12% (p = 0.007; Table 2), suggesting
that the relationship between changes in
MDI and BPb was different for the two
iron groups.
To test this interaction further, we ana-
lyzed onlythose children who remained iron
deficient throughout the 6 months (n = 10)
and those who remained sufficient through-
out (n = 17). Though the numbers are
smaller, the results were ofthe same magni-
tude and still significant (increase in R2 =
15.2%, p = 0.03). We also conducted the
same analyses using raw scores from the
Bayley rather than the standardized scores.
Some MDI scores had to be extrapolated
from the norms (13) for children who
became too old for the norms at some point
during the 6 months. Using raw scores
bypasses any potential problems with the
extrapolation; even so, the analysis of the
raw scores reveals the same significant inter-
action (increase in R2 = 7.3, p = 0.03). We
are confident, therefore, about the interac-
tion between change in BPb and iron status.
The relationship between changes in
MDI and changes in BPb was then assessed
separately for the two groups. The iron-
deficient group showed no relationship
between cognitive and BPb changes (D =
0.038, p = 0.91). The iron-sufficient
group, in contrast, showed a large and sig-
nificant relationship (o = -1.22, p = 0.009).
The change in BPb contributed 33% to the
R2 and thus explained considerable vari-
ance in MDI change beyond that account-
ed for by initial levels of both MDI and
BPb and the background covariates ofSES,
HOME score, and language oftest admin-
istration. The regression coefficient can be
interpreted as showing an increase of 1.2
points in MDI for every decrease of 1 pg/dl
of BPb. There were no bivariate outliers
with undue influence.
For descriptive purposes, the 21 iron-
sufficient children were categorized into
three subgroups according to changes in
BPb: large decreases in BPb (-22 to -11
,ug/dl), moderate decreases in BPb (-11 to
-6 pg/dl), and modest decreases or actual
increases (-6 to +2 pg/dl). Table 3 presents
the unadjusted and adjusted means for
MDI change and BPb change for these
three groups along with the mean initial
levels. As can be seen in the table, the
changes in MDI ranged from large increas-
es to large declines over time; thus, concep-
tually, both smaller decrements as well as
increases could be viewed as improvement.
In other words, declining BPb seemed to
be related to both a halting of decline in
MDI and to facilitation of development
over the 6 months.
Age equivalents on the perceptual-
motor and language subscales ofthe Bayley
as scored by the Kent system (unpublished
manuscript) were examined next. There
was an interaction between change in BPb
and iron status observed with the perceptu-
al-motor score (3 = -0.22, p = 0.055).
When the two iron groups were analyzed
separately, there was, again, no relationship
for the iron-deficient children (,B = 0.01, p
= 0.93), but a sizeable and significant rela-
tionship in the iron-sufficient children (1B =
-0.27, p = 0.007). For every decrease of 1
pg/dl in BPb, iron-sufficient children
gained about 0.25 months on the perceptu-
al-motor subscale. Table 3 shows adjusted
and unadjusted means for the BPb-change
subgroups. Note that a score in age equiva-
lents almost always increases because chil-
dren usually pass at least as many items on
a second testing; the MDI, in contrast,
may decrease because a child passes fewer
items than expected for an average rate of
development. There was no relationship
between BPb changes and changes on the
language subscale in either the iron-suffi-
cient or iron-deficient groups. Thus, rela-
tionships between changes in cognitive
functioning and changes in BPb are seen
only in the iron-sufficient children, and
then only in the perceptual-motor subscale.
Changes in the Iron-Deficient Group
The absence of a systematic relationship
between BPb changes and changes in MDI
Table 4. Unadjusted and adjusted meansfor changes in Hb and MDI over 6 months forsubgroups based
on degree of change in Hb
Change in Hb Change in MDI
(g/dl) (standardized points)
Hb change groups Hb1 Unadjusted Adjusted8 MDI1 Unadjusted Adjustedb
Large increases (n=7) 10.7 + 1.47 +1.44 76.3 +2.40 +2.90
Medium increases (n=7) 11.4 +0.40 + 0.43 77.7 -2.40 -2.14
Small increases/declines (n= 7) 11.6 -0.36 -0.35 82.3 -6.00 - 6.19
Abbreviations: Hb, hemoglobin; MDI, mental development index of Bayley Scale.
aAdjusted for Hb attime 1 (Hb1).
bAdjusted for Hb and MDI attime 1 (MDI1).
in the iron-deficient group may result from
other factors that obscure the relationship.
These other factors may affect changes in
MDI over time, or they may influence
changes in BPb over time. To explore these
possibilities, changes in the MDIs of the
iron-deficient group were tested against
changes in the iron and hematologic
indices. There was no relationship with
changes in ferritin, but changes in Hb and
MCV were both significantly related to
changes in MDI (1 = 5.07 and 1.29, p <
0.05). After entering the initial levels of
MDI and Hb, SES, HOME score, and lan-
guage of test administration as covariates
and potential confounders, the addition of
change in Hb accounted for an increase of
11% in the R2 (p = 0.08). The change in
MCV also accounted for 10% ofthe vari-
ance (p = 0.08). These two indices are
related to one another (r = 0.57,p = 0.007)
at time 1, and here we pursue Hb only.
One child had undue influence in the
opposite direction; when that child's data
are omitted, the relationship between MDI
change and Hb change is even stronger,
with change in Hb accounting for 19%
increase in the R2 over the initial values
and the background variables (p = 0.02).
When the data for all sample children with
Hb values at time 3 were entered into an
analysis, the interaction between change in
Hb and iron status was significant (p =
0.05); that is, only for iron-deficient chil-
dren was the relationship significant.
The iron-deficient children were then
divided for descriptive purposes into three
equal groups according to degree ofchange
in Hb: substantial increases in Hb (+0.8 to
2.3 g/dl); modest increases (+0.2 to +0.7
g/dl); and very small increases or decreases
(+0.1 to -1.0 g/dl). Adjusted means for
both change in MDI and change in Hb
were calculated with control for the initial
levels as well as the background variables
and are presented in Table 4. The largest
increases in hemoglobin were related to
increases in MDI, but moderate to small
increases or decreases in Hb were associated
with declines in MDI. Unadjusted scores
showed the same pattern. The distribution
ofchildren with anemia at time 1 was 5, 3,
and 2 for the three groups, respectively.
When we examined change in BPb in
the two groups, the iron-deficient group
had about halfthe reduction in BPb ofthe
iron-sufficient group (-4.8 jig/dl vs. -8.5
pg/dl, F(1,40) = 4.3, p <0.05). The results
were virtually the same with initial BPb
level and sex controlled (-4.9 vs. -8.4 pg/dl,
p = 0.07). Although the iron-deficient and
iron-sufficient children were not signifi-
cantly different in their BPbs at time 1,
more iron-deficient children were below
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the median of 29 1ig/dl (13 vs. 7), raising
the possibility that the iron-deficient chil-
dren may have had somewhat less room for
change in BPb. However, when we com-
pared only children who were above the
median on BPb at time 1, the iron-defi-
cient children still had significantly lower
reductions in BPb [F (1,18) = 7.2, p =
0.015]. These results suggest that iron-defi-
cient children with moderately elevated
BPb may have more difficulty in correcting
elevated blood leads than children who are
sufficient in iron.
Discussion and Conclusions
There were several interesting results ofthis
study. The first was the striking relation-
ship between changes in BPb and changes
in cognitive performance over a 6-month
period for iron-sufficient children who par-
ticipated in a comprehensive intervention
program. Because of the observational
nature of the study, it is not possible to
make definitive causal statements; however,
degree ofimprovement in cognitive perfor-
mance was related to the degree ofchange
in BPb in a linear fashion, suggesting that
cognitive development may be directly
related to declining BPb levels. Given the
comprehensive nature of the intervention,
we cannot attribute the decline in BPb to
anyparticular component.
Follow-up analyses indicated that the
relationship was strongest between change
in BPb and change in perceptual-motor per-
formance, a finding that is consistent with
the results ofsome ofthe recent prospective
studies (2,4,5,9). One potential problem in
interpretation stems from the lack ofa con-
current relationship between initial BPb
level and performance on the cognitive test
at time 1. To some extent, this may reflect a
restriction in range ofthe initial values; the
range in initial BPb levels was, by design,
restricted to the moderately elevated level;
the observed standard deviation in MDI
scores was less than the normative standard
deviation (11.5 vs. 16). The change scores,
on the other hand, had considerably higher
coefficients of variation than the initial
scores (37% vs. 21% in the case of BPb;
48% vs. 15% in the caseofMDI).
Another explanation is more theoreti-
cal. A delay in the effects oflead on cogni-
tion may result in children's performance
being more related to earlier levels than
concurrent levels of BPb. A survey of the
literature from the prospective studies sug-
gests such a possibility. Although there are
occasional reports of concurrent relation-
ships between BPb and cognitive function-
ing (8,5), it is more common for cognitive
functioning to be related to earlier BPb lev-
els. For example, Bellinger et al. (27) found
that MDI scores in the first 2 years of life
were related to umbilical cord BPb, but not
to concurrent blood lead levels. Wigg et al.
(28) found that MDI scores at 2 years were
related to BPb at 6 months but not to con-
current BPb levels. Bellinger et al. (2,3)
found a relationship ofBPb at 2 years with
later cognitive functioning but not with
concurrent cognitive functioning. In the
Australian prospective study, McMichael et
al. (5) reported relationships between cog-
nitive functioning at 4 years and BPb val-
ues at 2 and 3 years, but no correlation
with BPb at 4 years, when appropriate
covariates were controlled. If such a delay
were operating here, then the initial cogni-
tive performance of the children in our
sample would have been determined more
by their history with exposure to lead than
by their current BPb levels. The 6-month
course of the study was presumably long
enough to detect a relationship between
the changes in lead levels and changes in
cognition without those changes having to
be strictly contemporaneous. Further inves-
tigation would be needed to clarify this
possibility.
It is not clear how low iron levels inter-
fere with the observed relationship between
declining BPb and cognitive functioning.
Low levels ofiron may slow down the rate
at which lead can be excreted and increase
the rate at which lead is absorbed (15,1),
leading to less predictable changes in lead
levels. The significantly lower reduction in
BPb over the course of 6 months in the
iron-deficient group would support such a
possibility. Another factor is that iron levels
are associated with cognitive performance,
either directly or indirectly, thus complicat-
ing the relationship between lead and cog-
nition. This possibility is supported by our
findings that the performance of the iron-
deficient children seems to change along
with changes in Hb and MCV. In this
group, there was also an association
between Hb and Bayley MDI at time 1. In
other words, the lower the Hb at time 1,
the lower the MDI; over time, the more
Hb increased, the more MDI increased.
We cannot entirely rule out some third
variable that is related to both increases in
Hb and improvements in performance. For
example, compliance with the therapeutic
regimen of oral iron might be related to
some background factor that was also relat-
ed to cognitive development. However, no
background variable, including maternal
IQ, quality ofhome environment, or SES,
eliminated the significant association
between Hb and MDI when entered into
the equation.
Another hypothetical possibility is that
the anemic children, who showed the
largest increases in Hb, as expected, were
initially more shy and fearful than children
with higher initial Hb and smaller increas-
es. The MDIs of the anemic children may
then have increased more from time 1 to
time 3 because they were significantly more
comfortable with the test situation at time
3 (29). We do not have the measures to
determine whether, in fact, the anemic
children were more fearful initially.
However, because MDI change was related
to change in Hb in a linear fashion,
noncognitive factors like fearfulness would
more likely be mediators, rather than con-
founders, of the relationship between cog-
nitive and hematologic changes.
Ifthe association is not a spurious one,
the iron-deficient children's performance
might conceivably have been influenced
directly by oxygenation of neural tissue or
indirectly by increasing energy and thus
attention and motivation. The findings
were not limited to the anemic children, a
fact that is consistent with some previous
literature and not others. Walter et al. (30)
and Oski et al. (31) report improvements
in the cognitive scores of iron-deficient,
nonanemic children after short-term iron
therapy, while Lozoff et al. (32) found
changes only in the anemic children. Only
a few investigators, however, have reported
changes in hematologic indices as continu-
ous variables (33,34), a potentially power-
fu.l way to detect associations between bio-
logical and behavioral variables.
In summary, there seem to be at least
two biochemical changes associated with
changes in the children's cognitive perfor-
mance in this study; one is improvement in
hematologic indices in iron-deficient chil-
dren and the other is decline in BPb in
iron-sufficient children. The number of
subjects is relatively small, but the results, if
replicated, would have important implica-
tions for our understanding of the way
multiple biological factors interact to influ-
ence the behavior and functioning of
young children.
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